Reglan Information Center: __________________ Possible Cause of Tardive Dyskinesia Common Questions about Reglan Reglan Litigation What is Tardive Dyskinesia What is Reglan (Metoclopramide) What is GERD or Reflux Tardive Dyskinesia Described We will work under a Contingency Fee Contract

Reglan is a prescription drug used to treat gastrointestinal disorders such as heartburn caused by reflux. The FDA recently required a black box warning linking Reglan and Tardive Dyskinesia. Symptoms of Tardive Dyskinesia include involuntary and repetitive movements like tongue thrusting, eye blinking and head jerking as well as involuntary movements of the fingers. These symptoms are rarely reversible with any known treatment. Those at increased risk for developing Tardive Dyskinesia are the elderly, especially older women, and people who have taken the drug for a long period of time. The FDA has advice physicians to avoid long term use of Reglan and recommends treatment not exceed three months. Reglan is available in formulations including tablets, syrups and injection.

We are evaluating cases where we can confirm extended use of Reglan along with a doctor’s diagnosis or confirmed symptoms of the condition known as Tardive Dyskinesia.

The following is an important medical alert.  In late February 2009, the FDA ordered the manufacturers of Reglan and its generic equivalent, metoclopramide, to add a black-box warning alerting patients of an increased risk of a type of involuntary movement disorder known as tardive dyskinesia.  

If you or a family member have been diagnosed with tardive dyskinesia, call our Office at 1-800-862-1260.

Reglan and metoclopramide were orginally designed to treat gastrointestinal disorders, including gastroesophageal reflux disease and diabetic gastroparesis. The drugs Reglan and metoclopramide work by increasing the movement of the stomach muscles, which speeds up the rate at which the stomach empties into the intestines.

It is important that you and your family are aware that the FDA has issued a warning that Reglan and metoclopramide may cause tardive dyskinesia, a condition which can cause repeated, involuntary movements of the extremities. Other symptoms of tardive dyskinesia include involuntary grimacing, lip movements, blinking, rapid eye movement, sticking out the tongue and problems moving the fingers. Several recent studies have found that Reglan and its generic version, metoclopramide, are the most frequent causes of drug-induced movement disorders.

These known side effects of Reglan and metoclopramide are especially serious because tardive dyskinesia has no known treatment and the symptoms of the disease are rarely reversible. The FDA says that in some cases of tardive dyskinesia, these symptoms may become less severe after a patient stops taking Reglan or metoclopramide.

Several recent studies have found that Reglan and metoclopramide are the most frequent causes of drug-induced movement disorders. One study showed that about 20% of patients who took one of the two drugs for more than three months developed tardive dyskinesia.

Because of the risk of Reglan side effects, the FDA has advised physicians that the drugs should only be used in cases where the benefits of treatment outweigh the risks. Patients who have been taking one of the drugs for an extended period of time and elderly patients, especially women, are at the greatest risk of developing tardive dyskinesia. If you or a loved one have developed symptoms of tardive dyskinesia after taking Reglan or metoclopramide to treat a stomach disorder, contact the law office of Carabin & Shaw P.C. to discuss your legal rights and your case. You can contact us by calling our toll-free number at 1-800-862-1260, or by filling out a free case evaluation form to the right of this page.

If you or a family member have been diagnosed with tardive dyskinesia, call our Office at 1-800-862-1260.






























TRADEMARK NOTICE: Reglan is a trademark of Schwarz Pharma.

The Carabin & Shaw Law Firm, its' lawyers and this website is in no way affiliated with Schwarz Pharma. The use of this mark is solely for informational and product identification purposes.